Danaher Initiated at Equal-Weight by Wells Fargo
Danaher Analyst Ratings
Morgan Stanley Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,106
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101
Eli Lilly Analyst Ratings
Hold Rating on Abbott Laboratories Amid NEC Litigation Uncertainties
Jefferies Maintains Abbott Laboratories(ABT.US) With Hold Rating, Raises Target Price to $120
Evercore ISI Raises Price Target on AbbVie to $192 From $180, Keeps Outperform Rating
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Eli Lilly & Co (LLY) Receives a Buy From Barclays
AbbVie Analyst Ratings
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $209
Piper Sandler Sticks to Its Buy Rating for AbbVie (ABBV)
BTIG Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
Berenberg Bank Reaffirms Their Hold Rating on Pfizer (PFE)
Abbott Laboratories Analyst Ratings
Citi Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $127
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101